Data as of Dec 11
| -0.13 / -2.81%|
The 3 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 7.25, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +61.47% increase from the last price of 4.49.
The current consensus among 3 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.